References
  1. Biondi A, Cimino G, Pieters R, Pui CH. Biological and therapeutic aspects of infant leukemia. Blood 2000;96:24-33.
  2. Hilden JM, Dinndorf PA, Meerbaum SO, et al. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children’s Oncology Group. Blood. 2006;108:441–451.
  3. Ludwig WD, Bartram CR, Harbott J, et al. Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia. Leukemia. 1989;3:431–439.
  4. Heerema NA, Arthur DC, Sather H, et al. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Children’s Cancer Group. Blood. 1994;83:2274–2284.
  5. Chessells JM, Harrison CJ, Kempski H, et al. Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party. Leukemia. 2002;16:776–784.
  6. Corona-Rivera A, Bobadilla-Morales L, Cruz-Osorio RM, Ortega-de-la-Torre C, Gallegos-Castorena S, Sánchez-Zubieta F. A translocation t(5;15)(q15;q11-13) infant case with acute lymphoblastic leukemia and literature review: prognosis implications. J Pediatr Hematol Oncol. 2012 Jul;34(5):368-71.
  7. Johnson KJ, Roesler MA, Linabery AM, Hilden JM, Davies SM, Ross JA. Infant leukemia and congenital abnormalities: a Children’s Oncology Group study. Pediatr Blood Cancer. 2010 Jul 15;55(1):95-9.
  8. Arthur DC, Heerema NA, Reaman GH, Sather H, Bradley C, Hammond D: A new recurring translocation in acute lymphoblastic leukemia (ALL) in infants: t(5; 15)(p15;qllor13). Blood 70274a, 1987 (abstr, suppl1)
  9. Hee Lee S, Kim IS, Eun Jun S, Tak Lim Y, Yup Lee E. Translocation t(5;15)(p15;q11-q13) childhood acute lymphoblastic leukemia with heterogeneous prognosis implications. J Pediatr Hematol Oncol . 2014;36(8):656‐657.
  10. Kwon YJ, Lee JW, Kim MS, et al. Cytogenetic analysis in childhood acute lymphoblastic leukemia: experience at a single institution in Korea. Int J Hematol . 2009;89(2):150‐158.
  11. Pinette M, Garcia L, Wax JR, Cartin A, Blackstone J. Familial ectrodactyly. J Ultrasound Med . 2006;25(11):1465‐1467.
  12. Sharma D, Kumar C, Bhalerao S, Pandita A, Shastri S, Sharma P. Ectrodactyly, Ectodermal Dysplasia, Cleft Lip, and Palate (EEC Syndrome) with Tetralogy of Fallot: A Very Rare Combination. Front Pediatr . 2015;3:51.
  13. Bernardini L, Palka C, Ceccarini C, et al. Complex rearrangement of chromosomes 7q21.13-q22.1 confirms the ectrodactyly-deafness locus and suggests new candidate genes. Am J Med Genet A . 2008;146A(2):238‐244.
  14. Wieland I, Muschke P, Jakubiczka S, Volleth M, Freigang B, Wieacker PF. Refinement of the deletion in 7q21.3 associated with split hand/foot malformation type 1 and Mondini dysplasia. J Med Genet . 2004;41(5):e54.
  15. Roganovic J, Radojcic-Badovinac A, Ahel V. Increased prevalence of minör anomalies in children with hematologic malignancies. Med Pediatr Oncol. 2002;38(2):128-30.
  16. Loder RT, Huffman G, Toney E, Wurtz LD, Fallon R. Abnormal rib number in childhood malignancy: implications for the scoliosis surgeon. Spine (Phila Pa 1976) . 2007;32(8):904‐910.
  17. Agha MM, Williams JI, Marrett L, et al. Congenital abnormalities and childhood cancer. Cancer. 2005; 103:1939–1948.
Figure 1. A.B. Photos and C radiograph of patient showing ectrodactyly on right hand.
Figure 2. Patient’s karyotype analysis of bone marrow at diagnosis: 46,XX, t(5;15)(p15;q11.2)[3]/46,XX[17]